Hirudin promotes proliferation and osteogenic differentiation of HBMSCs via activation of cyclic guanosine monophosphate (cGMP)/protein kinase-G (PKG) signaling pathway

References

• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381.
   PubMed Web of Science ®Google Scholar
• Farr JN, Khosla S. Skeletal changes through the lifespan – from growth to senescence. Nat Rev Endocrinol. 2015;11(9):513–521.
   PubMed Web of Science ®Google Scholar
• Cauley JA. Osteoporosis: fracture epidemiology update 2016. Curr Opin Rheumatol. 2017;29(2):150–156.
   PubMed Web of Science ®Google Scholar
• Shafaei H, Kalarestaghi H. Adipose-derived stem cells: an appropriate selection for osteogenic differentiation. J Cell Physiol. 2020;235(11):8371–8386.
   PubMed Web of Science ®Google Scholar
• Liang T, Gao W, Zhu L, et al. TIMP-1 inhibits proliferation and osteogenic differentiation of hBMSCs through Wnt/٢-catenin signaling. Biosci Rep. 2019;39(1). DOI:10.1042/BSR20181290.
   Google Scholar
• Supakul S, Yao K, Ochi H, et al. Pericytes as a source of osteogenic cells in bone fracture healing. Int J Mol Sci. 2019;20(5). DOI:10.3390/ijms20051079.
   PubMed Web of Science ®Google Scholar
• Zhao L. Hirudin inhibits cell growth via ERK/MAPK signaling in human glioma. Int J Clin Exp Med. 2015;8(11):20983–20987.
   PubMed Web of Science ®Google Scholar
• Gong X, Zhang Q, Tan S. Inhibitory effect of r-hirudin variant III on streptozotocin-induced diabetic cataracts in rats. ScientificWorldJournal. 2013;2013:630651.
   PubMedGoogle Scholar
• Li DQ, Zhou YP, Yang H. Donepezil combined with natural hirudin improves the clinical symptoms of patients with mild-to-moderate Alzheimer’s disease: a 20-week open-label pilot study. Int J Med Sci. 2012;9(3):248–255.
   PubMed Web of Science ®Google Scholar
• Fujita K, Otsuka T, Kawabata T, et al. HSP90 limits thrombin ∞stimulated IL º∞6 synthesis in osteoblast∞like MC3T3°∞E1 cells: regulation of p38 MAPK. Int J Mol Med. 2018;42(4):2185–2192.
   PubMed Web of Science ®Google Scholar
• Kaneshiro S, Ebina K, Shi K, et al. IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro. J Bone Miner Metab. 2014;32(4):378–392.
   PubMed Web of Science ®Google Scholar
• Winkler T, Perka C, Matziolis D, et al. Effect of a direct thrombin inhibitor compared with dalteparin and unfractionated heparin on human osteoblasts. Open Orthop J. 2011;5(1):52–58.
   PubMedGoogle Scholar
• Zhai YK, Guo X-Y, Ge B-F, et al. Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG. Bone. 2014;66:189–198.
   PubMed Web of Science ®Google Scholar
• Lv H, Che T, Tang X, et al. Puerarin enhances proliferation and osteoblastic differentiation of human bone marrow stromal cells via a nitric oxide/cyclic guanosine monophosphate signaling pathway. Mol Med Rep. 2015;12(2):2283–2290.
   PubMed Web of Science ®Google Scholar
• Kobsar A, Koessler J, Kehrer L, et al. The thrombin inhibitors hirudin and Refludan() activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets. Thromb Haemost. 2012;107(3):521–529.
   PubMed Web of Science ®Google Scholar
• Li Y, Bian M, Zhou Z, et al. Circular RNA SIPA1L1 regulates osteoblastic differentiation of stem cells from apical papilla via miR-204-5p/ALPL pathway. Stem Cell Res Ther. 2020;11(1):461.
   PubMed Web of Science ®Google Scholar
• Qi M, Zhang L, Ma Y, et al. Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent estrogen deficiency-induced osteoporosis. Theranostics. 2017;7(18):4498–4516.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Dalle Carbonare L, Valenti MT, Zanatta M, et al. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009;60(11):3356–3365.
   PubMedGoogle Scholar
• Hu HM, Yang L, Wang Z, et al. Overexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathway. Int J Clin Exp Pathol. 2013;6(5):841–852.
   PubMed Web of Science ®Google Scholar
• Fan J-Z, Yang L, Meng G-L, et al. Estrogen improves the proliferation and differentiation of hBMSCs derived from postmenopausal osteoporosis through notch signaling pathway. Mol Cell Biochem. 2014;392(1–2):85–93.
   PubMed Web of Science ®Google Scholar
• Knobloch K, Gohritz A, Busch K, et al. Hirudo medicinalis-leech applications in plastic and reconstructive microsurgery – a literature review. Handchir Mikrochir Plast Chir. 2007;39(2):103–107.
   PubMedGoogle Scholar
• Whyte CS, Swieringa F, Mastenbroek TG, et al. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow. Blood. 2015;125(16):2568–2578.
   PubMed Web of Science ®Google Scholar
• Xia J, Sheng W, Pei L, et al. Effects of unfractionated heparin and rivaroxaban on the expression of heparanase and fibroblast growth factor 2 in human osteoblasts. Mol Med Rep. 2017;16(1):361–366.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen B, Li D, et al. LncRNA NEAT1/miR-29b-3p/BMP1 axis promotes osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. Pathol Res Pract. 2019;215(3):525–531.
   PubMed Web of Science ®Google Scholar
• Wang SN, Zhao X-Q, Yu B, et al. miR-193a inhibits osteogenic differentiation of bone marrow-derived stroma cell via targeting HMGB1. Biochem Biophys Res Commun. 2018;503(2):536–543.
   PubMed Web of Science ®Google Scholar
• Cheng F, Yang MM, Yang RH. MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2. Eur Rev Med Pharmacol Sci. 2019;23(18):7766–7774.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiang S, Liu Q, et al. PPARgamma antagonizes hypoxia-induced activation of hepatic stellate cell through cross mediating PI3K/AKT and cGMP/PKG signaling. PPAR Res. 2018;2018:6970407.
   PubMed Web of Science ®Google Scholar
• Kim S-M, Yuen T, Iqbal J, et al. The NO-cGMP-PKG pathway in skeletal remodeling. Ann N Y Acad Sci. 2021;1487(1):21–30.
   PubMed Web of Science ®Google Scholar
• Wisanwattana W, Wongkrajang K, Cao D-Y, et al. Inhibition of phosphodiesterase 5 promotes the aromatase-mediated estrogen biosynthesis in osteoblastic cells by activation of cGMP/PKG/SHP2 pathway. Front Endocrinol (Lausanne). 2021;12:636784.
   PubMed Web of Science ®Google Scholar
• Ramdani G, Schall N, Kalyanaraman H, et al. cGMP-dependent protein kinase-2 regulates bone mass and prevents diabetic bone loss. J Endocrinol. 2018;238(3):203–219.
   PubMed Web of Science ®Google Scholar